Sernova
Share
Sernova is a clinical-stage regenerative medicine theraupeutics company
Did you know, beta cells are responsible for producing insulin, the hormone that helps regulate blood glucose levels? In people living with ( ), these insulin-producing cells are destroyed by the immune system.
With our Cell Pouch bio-hybrid organ, we aim to support the long-term survival and function of therapeutic cells to help reduce the burden of T1D. Learn more about our approach: https://sernova.com/our-focus/type-1-diabetes/
06/19/2026
Last week at the , our team connected with key opinion leaders, industry peers, and members of the diabetes community for discussions about innovation in ( ) research.
As part of these important conversations about the needs of people living with T1D, we highlighted our advancement of the Cell Pouch bio-hybrid organ and its potential to provide a functional cure for T1D.
Thank you to all for a great conference!
Learn more about us:
Innovating Regenerative Medicine | About Sernova Meet the team committed to advancing durable solutions for patients living with chronic disease.
This , we are recognizing the unique ways impacts women differently.
Hormonal changes can affect blood glucose levels and increase variability. These differences highlight the need for more personalized, adaptable treatments, reflecting our mission to develop an approach designed for all people living with .
Learn more: https://bit.ly/4bs4Ui0
04/29/2026
Our Cell Pouch Bio-hybrid Organ offers the potential to be a transformational treatment solution for people with ( ) by reducing or eliminating the need for life-long insulin injections.
Learn more about our clinical data by reviewing the latest corporate presentation on our website: https://sernova.com/investors/
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
Sernova Biotherapeutics 700 Collip Circle, Ste 114
London, ON
N6G4X8
